BridgeMD
New treatment option for Prelabor Rupture of Membranes
Official title Impact of Early Rupture of the Residual Membrane on Latency Before Labour Begins
ClinicalTrials.gov ID: NCT07301957
What this study is testing
- What it's testing
- Approximately 25% of patients experience premature rupture of membranes before labour. Of these patients, 82% will give birth within 24 hours and 97% within 48 hours.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Women over 18 years of age
- Single foetal pregnancy, cephalic presentation
- diagnosis of membrane rupture with persistence of one membrane and absence of immediate spontaneous labour.
- Person affiliated with or beneficiary of a social security scheme
- Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination...
You likely can't join if
- Minor patient
- patient under guardianship/curatorship,
- multiple pregnancy, pregnancy with foetal death
- non-cephalic presentation
- gestational age less than 37 weeks,
- rupture of membranes more than 12 hours ago
See the full eligibility criteria
- Women over 18 years of age
- Single foetal pregnancy, cephalic presentation
- diagnosis of membrane rupture with persistence of one membrane and absence of immediate spontaneous labour.
- Person affiliated with or beneficiary of a social security scheme
- Free, informed and written consent signed by the participant and the investigator (no later than the day of inclusion and before any examination required by the research).
- Minor patient
- patient under guardianship/curatorship,
- multiple pregnancy, pregnancy with foetal death
- non-cephalic presentation
- gestational age less than 37 weeks,
- rupture of membranes more than 12 hours ago
- contraindication to vaginal deliver
- meconium-stained amniotic fluid,
- clinical signs suggestive of intrauterine infection (maternal hyperthermia \>38°C, maternal and/or foetal tachycardia, purulent amniotic fluid),
- cervix not accessible for artificial rupture
- vaginismus
- contraindication to a potential expectant management
- indication for induction for another reason
The study team makes the final eligibility decision.
Where it's taking place
- Angers, France
- Le Mans, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Angers, France; Le Mans, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.